SCHEMBL8779060

SCHEMBL8779060

C=C1c2cccc(Cl)c2CCC12CCCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.37
BCHE P06276 1/20 0.33
CYP19A1 P11511 2/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
ACHE P22303 1/20 0.33
HTR5A P47898 2/20 0.32
HTR1A P08908 1/20 0.32
HTR1D P28221 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR7 P34969 1/20 0.32
HTR3A P46098 1/20 0.32
ADRA2A P08913 1/20 0.31
CYP2D6 P10635 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779031 0.80 SIGMAR1 (0.40) KDM1ABCHEHTR2AHTR2CPDE7A
SCHEMBL8779104 0.77 ADRA2A (0.35) ADRA2A
SCHEMBL11768992 0.76 MAPT (0.33) KDM1ABCHEADRA2AADRA2BADRA2C
SCHEMBL8779076 0.73 PNMT (0.34) ACHEHTR5AADRA2ACYP2D6ADRA2B
SCHEMBL8778991 0.72 SIGMAR1 (0.44) HTR2AHTR2C
SCHEMBL8778969 0.69 KDM1A (0.34) KDM1A
Hydrochloric Acid SCHEMBL11810210 0.69 KDM1A (0.37) KDM1A
SCHEMBL20423549 0.68 SIGMAR1 (0.44) HTR2AHTR2C
SCHEMBL8778955 0.68 AR (0.33)
SCHEMBL8779056 0.67 F7 (0.39) KDM1ACYP19A1CYP11B1CYP11B2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed